Amgen Amgen (NASDAQ: AMGN) is a biotech with a portfolio of more than a dozen different drugs that it sells to millions of people around the world. Ideally, investors should target dividend-growth stocks that raise their payouts over time to ensure that inflation won't chip away at the purchasing power of the dividend payments. During the quarter, it processed $1.7 trillion worth of transactions, an increase of 14% from the prior-year period, suggesting that spending is still very strong among cardholders.